Evidence map›Paper›PMID 26775713›Full record

ArticleCNS neuroscience & therapeutics2016

Locus Coeruleus Dysfunction in Transgenic Rats with Low Brain Angiotensinogen.

Michael Ogier, Giampiero Bricca, Michael Bader, Laurent Bezin

Open access · bronzeAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 4 countries.

Michael OgierINSERM U1028, CNRS UMR5292, University Claude Bernard Lyon 1, Lyon Neuroscience Research Center, Team TIGER, Lyon, France.
Giampiero BriccaEA 4173, University Lyon 1, Lyon, France.
Michael BaderMax-Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
Laurent BezinINSERM U1028, CNRS UMR5292, University Claude Bernard Lyon 1, Lyon Neuroscience Research Center, Team TIGER, Lyon, France.
Université Claude Bernard Lyon 1 · FRMax Delbrück Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTransgenic TGR(ASrAOGEN)680 (TGR) rats with specific downregulation of glial angiotensinogen (AOGEN) synthesis develop cardiovascular deficits, anxiety, altered response to stress, and depression. Here, we evaluated whether these deficits are associated with alteration of the integrity of the noradrenergic system originating from locus coeruleus (LC) neurons.

methodsAdult TGR rats were compared to control Sprague Dawley rats in terms of the following: tissue levels of transcripts encoding noradrenergic markers, tissue tyrosine hydroxylase (TH) protein level, in vivo TH activity, density of TH-containing fibers, behavioral response to novelty, locomotor activity, and polysomnography.

resultsTH expression was increased in the LC of TGR rats compared to controls. In LC terminal fields, there was an increase in density of TH-containing fibers in TGR rats that was associated with an elevation of in vivo TH activity. TGR rats also displayed locomotor hyperactivity in response to novelty. Moreover, polysomnographic studies indicated that daily paradoxical sleep duration was increased in TGR rats and that the paradoxical sleep rebound triggered by total sleep deprivation was blunted in these rats.

conclusionsAltogether, these results suggest that disruption of astroglial AOGEN synthesis leads to cardiovascular, cognitive, behavioral, and sleep disorders that might be partly due to LC dysfunction.

Indexed as

AngiotensinogenAnimalsBody TemperatureCase-Control StudiesCerebellumDopamine beta-HydroxylaseGene Expression RegulationGlial Fibrillary Acidic ProteinLevodopaLocus CoeruleusMaleMotor ActivityNeuronsNorepinephrine Plasma Membrane Transport ProteinsRatsRats, Sprague-DawleyAngiotensinogenDopamine beta-HydroxylaseGlial Fibrillary Acidic ProteinLevodopaNorepinephrine Plasma Membrane Transport ProteinsSlc6a2 protein, ratTyrosine 3-MonooxygenaseAngiotensinAstrocytesBrainstemTransgenic ratsTyrosine hydroxylase

Identifiers

PMID26775713
PMCPMC6492901
OpenAlexW2471875805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.